Halima El Omri

799 total citations
47 papers, 355 citations indexed

About

Halima El Omri is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Halima El Omri has authored 47 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 11 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Halima El Omri's work include Chronic Lymphocytic Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (6 papers) and Acute Myeloid Leukemia Research (6 papers). Halima El Omri is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (6 papers) and Acute Myeloid Leukemia Research (6 papers). Halima El Omri collaborates with scholars based in Qatar, Tunisia and United States. Halima El Omri's co-authors include Ruba Y. Taha, Saba Hasan, Adel Elomri, Shahab Uddin, Abdelfatteh El Omri, Said Dermime, Abdul Quaiyoom Khan, Sabah Akhtar, Shilpa Kuttikrishnan and Maysaloun Merhi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Halima El Omri

42 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Halima El Omri Qatar 10 136 87 75 49 47 47 355
Ruba Y. Taha Qatar 10 97 0.7× 42 0.5× 67 0.9× 42 0.9× 44 0.9× 40 331
Yousun Chung South Korea 10 80 0.6× 92 1.1× 30 0.4× 9 0.2× 14 0.3× 64 375
G. Wesley White United States 12 89 0.7× 127 1.5× 140 1.9× 102 2.1× 18 0.4× 19 569
Kumiko Ueda Japan 13 232 1.7× 17 0.2× 121 1.6× 24 0.5× 106 2.3× 48 554
Yingchun Luo China 12 141 1.0× 31 0.4× 39 0.5× 7 0.1× 32 0.7× 43 489
Bo Jin China 11 225 1.7× 80 0.9× 52 0.7× 15 0.3× 101 2.1× 25 510
S. Vishnupriya India 16 267 2.0× 77 0.9× 131 1.7× 18 0.4× 80 1.7× 50 612
Yuko Tanaka Japan 12 239 1.8× 45 0.5× 51 0.7× 29 0.6× 39 0.8× 26 593
Kazufumi Yamagata Japan 12 60 0.4× 30 0.3× 61 0.8× 12 0.2× 14 0.3× 38 364

Countries citing papers authored by Halima El Omri

Since Specialization
Citations

This map shows the geographic impact of Halima El Omri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halima El Omri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halima El Omri more than expected).

Fields of papers citing papers by Halima El Omri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Halima El Omri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halima El Omri. The network helps show where Halima El Omri may publish in the future.

Co-authorship network of co-authors of Halima El Omri

This figure shows the co-authorship network connecting the top 25 collaborators of Halima El Omri. A scholar is included among the top collaborators of Halima El Omri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Halima El Omri. Halima El Omri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Omri, Halima El, et al.. (2024). Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review. Frontiers in Oncology. 14. 1390747–1390747. 1 indexed citations
2.
Al‐Khabori, Murtadha, et al.. (2024). Consensus-Based Guidelines for Acute Myeloid Leukemia Management in Gulf Cooperation Council Countries: Addressing Unmet Regional Needs and the Changing AML Landscape. JCO Global Oncology. 10(10). e2300165–e2300165. 1 indexed citations
3.
4.
Alkhatib, Mohammad, et al.. (2023). Refractory cold agglutinin disease successfully treated with daratumumab. A case report and review of literature. Hematology. 28(1). 2252651–2252651. 4 indexed citations
5.
Padmanabhan, Regina, et al.. (2023). An Artificial Intelligence-Based Diagnostic System for Acute Lymphoblastic Leukemia Detection. Studies in health technology and informatics. 305. 265–268. 4 indexed citations
6.
Omri, Halima El, Regina Padmanabhan, Ruba Y. Taha, et al.. (2023). Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009–2019). Journal of Infection and Public Health. 17(1). 152–162. 10 indexed citations
7.
Elomri, Adel, Laoucine Kerbache, Abdelfatteh El Omri, et al.. (2022). Bibliometric analysis of cancer care operations management: current status, developments, and future directions. Health Care Management Science. 25(1). 166–185. 16 indexed citations
8.
Omri, Halima El, Ruba Y. Taha, Adel Elomri, et al.. (2020). Acute Myeloid Leukemia in Qatar (2010–2016): Clinical, Biological, and Prognostic Factors and Treatment Outcomes. Frontiers in Genetics. 11. 553–553. 5 indexed citations
9.
Akhtar, Sabah, Iman W. Achkar, Kodappully Sivaraman Siveen, et al.. (2019). Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling. Frontiers in Oncology. 9. 285–285. 36 indexed citations
10.
Mohamed, Shehab, et al.. (2019). Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer: Case Report. Case Reports in Oncology. 12(3). 922–927. 3 indexed citations
11.
Prabhu, Kirti S., Kodappully Sivaraman Siveen, Shilpa Kuttikrishnan, et al.. (2018). Greensporone C, a Freshwater Fungal Secondary Metabolite Induces Mitochondrial-Mediated Apoptotic Cell Death in Leukemic Cell Lines. Frontiers in Pharmacology. 9. 720–720. 24 indexed citations
12.
Hasan, Saba, Ruba Y. Taha, & Halima El Omri. (2018). Current Opinions on Chemoresistance: An Overview. Bioinformation. 14(2). 80–85. 49 indexed citations
13.
Soliman, Dina Sameh, et al.. (2014). Rare aggressive natural killer cell leukemia presented with bone marrow fibrosis - a diagnostic challenge. SpringerPlus. 3(1). 390–390. 3 indexed citations
14.
Youssef, Yosra Ben, et al.. (2012). Nasopharyngeal/nasal type NK/T lymphoma: Analysis of 23 cases and current review of the literature. The Turkish Journal of Ear Nose and Throat. 22(5). 275–283. 4 indexed citations
15.
Omri, Halima El, et al.. (2012). Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs. Annales de biologie clinique. 70(6). 659–665. 3 indexed citations
16.
Taha, Ruba Y., et al.. (2010). Two Ocular Infections during Conventional Chemotherapy in a Patient with Acute Lymphoblastic Leukemia: A Case Report. Case Reports in Oncology. 3(2). 234–239. 5 indexed citations
17.
Omri, Halima El, et al.. (2010). Acquired pure megakaryocytic aplasia successfully treated with cyclosporine. Turkish Journal of Hematology. 27(4). 289–293. 1 indexed citations
18.
19.
Omri, Halima El, et al.. (2006). FIP1L1–PDGFRA positive chronic eosinophilic leukemia in Tunisian patients. Pathologie Biologie. 55(5). 242–245.
20.
Omri, Halima El, et al.. (2000). Contribution of Flow Cytometry to Acute Leukemia Classification in Tunisia. Disease Markers. 16(3-4). 131–133. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruba Y. Taha Breakdown of academic impact, for papers by Yousun Chung Breakdown of academic impact, for papers by G. Wesley White Breakdown of academic impact, for papers by Kumiko Ueda Breakdown of academic impact, for papers by Yingchun Luo Breakdown of academic impact, for papers by Bo Jin Breakdown of academic impact, for papers by S. Vishnupriya Breakdown of academic impact, for papers by Yuko Tanaka Breakdown of academic impact, for papers by Kazufumi Yamagata
Rankless by CCL
2026